{
  "resourceType" : "MedicationRequest",
  "id" : "MedicationRequestPembroChemoNeoadjuvantMamma",
  "meta" : {
    "profile" : ["https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-tumorboard-medication-request"]
  },
  "language" : "en",
  "text" : {
    "status" : "extensions",
    "div" : "<div xml:lang=\"en\" lang=\"en\"><hr/><p><b>English</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest MedicationRequestPembroChemoNeoadjuvantMamma</b></p><a name=\"en-MedicationRequestPembroChemoNeoadjuvantMamma\"> </a><a name=\"en-hcMedicationRequestPembroChemoNeoadjuvantMamma\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-onko-tumorboard-medication-request.html\">Tumorboard MedicationRequest</a></p></div><p><b>EnLiST-Änderungstyp (Extension)</b>: <span title=\"Codes:{https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-change-type new}\">New LoT</span></p><p><b>status</b>: Completed</p><p><b>intent</b>: Plan</p><p><b>category</b>: <span title=\"Codes:{http://loinc.org 85232-7}\">Tumor board Consult note</span></p><p><b>medication</b>: <span title=\"Codes:\">Pembrolizumab + Carboplatin/Paclitaxel, gefolgt von Pembrolizumab + Epirubicin/Cyclophosphamid (KEYNOTE-522)</span></p><p><b>subject</b>: <a href=\"Patient-PatientinMamma.html\">Sabine Baumann  Female, DoB: 1977-06-24</a></p></div>"
  },
  "extension" : [{
    "url" : "https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/enlist-change",
    "valueCodeableConcept" : {
      "coding" : [{
        "system" : "https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-change-type",
        "code" : "new",
        "display" : "New LoT"
      }]
    }
  }],
  "status" : "completed",
  "intent" : "plan",
  "category" : [{
    "coding" : [{
      "system" : "http://loinc.org",
      "code" : "85232-7",
      "display" : "Tumor board Consult note"
    }]
  }],
  "medicationCodeableConcept" : {
    "text" : "Pembrolizumab + Carboplatin/Paclitaxel, gefolgt von Pembrolizumab + Epirubicin/Cyclophosphamid (KEYNOTE-522)"
  },
  "subject" : {
    "reference" : "Patient/PatientinMamma"
  }
}